FDA Brief

Warning letters Drugs

FDA warning letter to

Legit Ketamine Suppliers / www.legitketaminesuppliers.com

High riskIssued Jun 23Posted Jul 7Center for Drug Evaluation and Research (CDER)

FDA warns Legit Ketamine Suppliers website for selling unapproved, misbranded ketamine and esketamine drugs to U.S. consumers.

What happened

FDA reviewed the website www.legitketaminesuppliers.com on February 26, 2026 (Establishment Identifier 3043543369) rather than conducting an inspection. The review found the site offering ketamine marketed as "ketamine buy" and esketamine marketed as "Ketamine Nasal Spray," with claims that they treat pain and treatment-resistant depression. FDA says no approved application exists for these products and that they are sold without a prescription.

What FDA found

  1. The website sold ketamine and esketamine products that FDA has never approved.

    FD&C Act sections 301(d) and 505(a) (21 U.S.C. 331(d), 355(a))
  2. Website claims that the products treat pain and depression show they are drugs intended for human use.

    21 CFR 201.128
  3. The labeling does not give adequate directions for use, so the drugs are misbranded.

    FD&C Act section 502(f)(1) (21 U.S.C. 352(f)(1))
  4. The company offers prescription drugs for sale without requiring a prescription.

    FD&C Act sections 503(b)(1) and 301(k) (21 U.S.C. 353(b)(1), 331(k))
  5. Unapproved drugs were introduced into interstate commerce, which the law prohibits.

    FD&C Act section 301(a) (21 U.S.C. 331(a))
  6. The esketamine nasal spray is sold without the restricted distribution and monitoring program (REMS) that the approved version requires.

What FDA wants

FDA tells the company to stop offering any unapproved and misbranded drugs for sale to U.S. consumers. The company must send a written response with corrective steps and supporting documents within 15 business days of receiving the letter, citing reference number MARCS-CMS 725149.

Who should pay attention

  • telehealth and online pharmacy operators
  • clinics and pharmacies that handle ketamine or esketamine
  • compounding pharmacies and brands selling ketamine products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk